Table of Content Download Sample

Preterm Labor Treatment Market: Information by Drugs (Tocolytic Drugs, Antibiotics Beta – Mimetic, Corticosteroids), Dosage Form (Tablets & Capsules, Injection), End User—Forecast Till 2026

Request Free Sample Report

Report Description

Global Statistics Representing Preterm Labor Treatment Market Scenario

Preterm Labor Treatment is a medical condition resulting in uterus contraction which brings about the changes in cervix starting approximately 37 weeks before pregnancy. Dilation in which cervix opens up for the entry of fetus into birth canal and effacement in which cervix thins out, are the two changes which are adapted by the cervix in Preterm Labor Treatment. It is a condition of severe concern as the babies born in Preterm Labor Treatment are generally unhealthy or are born with some sort of disabilities which may last for lifetime. Prevalence of Preterm Labor Treatment is increasing across the globe owing to the changing lifestyle and changing eating and drinking habits.

Global preterm labor treatment market was valued at USD 760.8 million in 2018, growing at a CAGR of 5.1% during the forecast period of 2019–2026.

Increasing Prevalence of Smoking and Alcohol Consumption

With the increasing hectic lifestyle and lifestyle related stress, women are becoming more prone to accept various means to release or relive stress. Today, a greater number of women across the globe are developing addiction for smoking and alcohol, especially in developed countries. The same trend is witnessed among pregnant women and its prevalence is increasing rapidly. In some studies, it has been found that the frequency of Preterm Labor Treatment is high among heavy and moderate smokers than normal individuals. For instance, according to the American Pregnancy Association, more than 1000 neonatal dies each year due to smoking in the U.S. and the number is likely to increase in the coming years.

Segmental Insights

For a better understanding of the global Preterm Labor Treatment market, we have segmented the market by drugs, dosage form and end user.

By drugs, the market is segmented into tocolytic drugs, antibiotics beta mimetic, corticosteroids, others. Tocolytic drugs is accounting for the 43.6% of the market. Tocolytic drugs are used to slow the uterine contractions and delay the delivery for a short time to buy some time for corticosteroids and magnesium sulfate treatment. Extended time also helps the patient to seek better treatment options, which is one of the major factors driving the demand for tocolytic drugs. Tocolytics are also used as a substitute for various drugs like salbutamol, which further supports the market growth. For Instance, in the U.S., the nifedipine (calcium channel blocker) is considered as the first line tocolytic drug with fewer side effects and perhaps a better safety profile compared to other agents.

Regional Insights

Global Preterm Labor Treatment market by Americas, Asia Pacific, Europe, and the Middle East and Africa.

North America is holding a considerable share of the global Preterm Labor Treatment treatment market. This can be attributed to moderate prevalence of premature birth, high healthcare expenditure, strong awareness among parents, huge women smoking population, and high acceptance of IVF.  The U.S. has the huge smoking and alcohol consuming populations. In 2016, the prevalence of smoking was higher around 18.9% in mothers aged between 20 and 29, and 5.2% in mothers aged between 30 and 34. Moreover, about 10% pregnant women in the U.S. consume alcohol and about 1% women are occasional drinkers. With the rapid adoption of advanced technologies such as IVF in the region, the prevalence of premature birth has also increased along with several complications during pregnancy. To cover these complications, physician is prescribing a range of preterm medicines.

Europe is second leading region in the forecast period backed by increasing prevalence of smoking and premature birth, favorable government reimbursement policies, and strong penetration of IVF treatment. A significant number of preterm born children live with several disabilities affecting their physical and mental developments, which affect their families. Therefore, governments are running various campaigns through social media and constructive dialogue to create awareness about preterm birth and various measures to overcome the problem. Europe also has a huge woman smoking population. According to the NHS Digital, about 11% pregnant European women smoked during 2018–19, which increased the chances of preterm birth as well as market for its treatment options.

Middle East & Africa Preterm Labor Treatment market to witness exponential growth in the coming years as result of improving healthcare facilities and rising number of teenage mothers. Additionally, growing urbanization, improving healthcare infrastructure, and high disposable income in the Middle East countries such as the UAE, Saudi Arabia, and Kuwait to boost the market growth. In Africa, the prevalence of preterm birth is higher than the Middle East countries on account of teenage pregnancy, poor healthcare infrastructure, and a smaller number of health checkups during pregnancy. However, the University of California has taken initiates to reduce the preterm birth in East Africa by providing better healthcare facilities to mother and newborn during pregnancy.

Key Players

Some of the prominent players in the Preterm Labor Treatment Market are Merck & Co., Inc., Pfizer Inc, Novartis AG, Sanofi, AstraZeneca, GlaxoSmithKline plc. and Cipla Inc.

Preterm Labor Treatment Market Segmentation

 By Drugs

  • Tocolytic Drugs
  • Antibiotics Beta – Mimetic
  • Corticosteroids
  • Others

By Dosage Form

  • Tablets & Capsules
  • Injection
  • Others

By End User

  • Hospitals
  • Nursing Homes
  • Pharmacy

Regions Covered


  • North America
    • U.S.
    • Canada
    • Mexico
  • South America


  • Western Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Eastern Europe


  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia-Pacific

Middle East

  • Saudi Arabia
  • UAE
  • Qatar
  • Rest of The Middle East


  • South Africa
  • Ghana
  • Nigeria

Frequently Asked Questions (FAQs)

The Global Preterm Labor Treatment Market was valued at USD 760.8 million in 2018, growing at a CAGR of 5.1% during the forecast period of 2019–2026.
Tocolytic drugs segment is expected to be leading segments in Preterm Labor Treatment Market during the forecast period.
In 2018 Global Preterm Labor Treatment Market was valued at USD 760.8 million.
Merck & Co., Inc., Pfizer Inc, Novartis AG, Sanofi, AstraZeneca, GlaxoSmithKline plc. and Cipla Inc are the top players in Preterm Labor Treatment Market.
North America is expected to hold the highest market share in Preterm Labor Treatment Market.

Copyright . All rights Reserved By Straits Research